Kazia Therapeutics Stock (NASDAQ:KZIA), Quotes and News Summary

Q: What sector and industry does Kazia Therapeutics (KZIA) operate in?

Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kazia Therapeutics Stock (NASDAQ: KZIA) stock price, news, charts, stock research, profile.

Open	$0.371
Close	-
Volume / Avg.	63.992K / 883.734K
Day Range	0.364 - 0.389
52 Wk Range	0.187 - 1.490
Market Cap	$9.938M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	-
Days to Cover	1

Recent News

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

Avi Kapoor

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

What's Going With Australia-Based Cancer Firm Kazia Therapeutics On Wednesday?

Kazia Therapeutics' Phase 1 trial of paxalisib with radiation therapy in solid tumors, demonstrates safety, clinical activity, and reaches primary endpoint.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Kazia Therapeutics Limited

Sector

Health Care

Industry

Biotechnology

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-canc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kazia Therapeutics (KZIA) stock?

You can purchase shares of Kazia Therapeutics (NASDAQ: KZIA) through any online brokerage.

View our list of the best stock brokerages.

Who are Kazia Therapeutics's (KZIA) competitors?

Other companies in Kazia Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR), Coeptis Therapeutics (NASDAQ:COEP) and Can Fite Biofarma (AMEX:CANF).

What is the target price for Kazia Therapeutics (KZIA) stock?

The latest price target for Kazia Therapeutics (NASDAQ: KZIA) was reported by HC Wainwright & Co. on Tuesday, April 11, 2023. The analyst firm set a price target for 2.00 expecting KZIA to rise to within 12 months (a possible 449.61% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Kazia Therapeutics (KZIA)?

The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $0.363897 last updated Today at April 23, 2024 at 10:10 AM EDT.

Does Kazia Therapeutics (KZIA) pay a dividend?

There are no upcoming dividends for Kazia Therapeutics.

When is Kazia Therapeutics (NASDAQ:KZIA) reporting earnings?

Kazia Therapeutics’s H1 earnings are confirmed for Tuesday, May 7, 2024.

Is Kazia Therapeutics (KZIA) going to split?

There is no upcoming split for Kazia Therapeutics.

What sector and industry does Kazia Therapeutics (KZIA) operate in?

Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-